R&D and Regulatory Affairs Director at Hipra Scientific Slu, Spain
Elia Torroella has more than 25 years of experience in the health industry around the world, focused on the prevention and vaccines industry. Such a vast experience has provided her with a good knowledge of and consistent relations with the pharmaceutical legislation authorities in the most important and demanding countries, including the European Union, the United States, Canada, Japan and China.
She is currently the R&D and Regulatory Affairs Director, and manages a team of more than 350 professionals in charge of the research, development and registration of high biotech vaccines, and who have made it possible for HIPRA to develop 22 innovative vaccines in the last 10 years. Nowadays, one of her main projects is the Covid-19 vaccine and the new projects for human health.
Torroella holds a Pharmacy degree from the Autonomous University of Barcelona, specialized in Analytical-Clinical.
Parallel Session: Hands-on acceleration and sustainability of healthcare innovation in COVID-19 times
- 8 November, 2021
- 10:00 - 11:30